EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered?

Thomas Theo Brehm, Niklas Köhler, Hans-Peter Grobbel, Jürgen Welling, Anna Maria Mandalakas, Vinicius Fava, Erwin Schurr, Christoph Lange

Infection · 2025

DOI: 10.1007/s15010-024-02470-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, 2025. Verfasst von Thomas Theo Brehm und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Parkallee 35, Borstel, Germany. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Forschungszentrum Borstel - Leibniz Lungenzentrum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Deciding whether to provide preventive treatment to contacts of individuals with multidrug-resistant (MDR) tuberculosis is complex.

Methods

We present the diagnostic pathways, clinical course and outcome of tuberculosis treatment in eight siblings from a single family. Tuberculosis disease was diagnosed by Mycobacterium tuberculosis culture and molecular detection of M. tuberculosis-specific DNA from bronchopulmonary specimens using GeneXpert ® MTB/RIF. M. tuberculosis infection was diagnosed by an interferon-gamma release assay (IGRA; QuantiFERON ® -TB Gold Plus). Whole exome sequencing for genetic predisposition to mycobacterial infection was performed in one patient.

Results

Six of eight siblings aged 16–20 years from a migrant family of Somali origin were diagnosed with pulmonary MDR tuberculosis over a 12-month period. The remaining male siblings, aged 11 and 14 years, were asymptomatic during contact investigation. Chest radiographs, computed tomography (CT) scans, sputum cultures and nucleic acid amplification tests were negative, and the IGRA did not detect M. tuberculosis infection. A repeat CT scan eight months later was unremarkable, and repeated sputum cultures remained negative. In the absence of sufficient evidence of M. tuberculosis infection, no preventive treatment was offered. At month seven of consistent clinical observation, both children were diagnosed with pulmonary tuberculosis; the older with advanced disease and subsequent post-tuberculosis lung disease. Whole exome sequencing revealed no Mendelian variant associated with susceptibility to mycobacterial infection.

Conclusion

When significant risk of tuberculosis transmission exists, close contacts of MDR tuberculosis patients should be offered preventive treatment with levofloxacin despite a negative IGRA test result.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, Multidrug-ResistantTuberculosis, PulmonaryHumansMaleAdolescentYoung AdultMycobacterium tuberculosisInterferon-gamma Release TestsAntitubercular AgentsChildFemaleContact TracingSomaliaAdult

Stichwörter der Autor:innen

IGRALTBIMDR/RR-TBMigrantTPT

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Department of Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Parkallee 35, Borstel, Germany.
  • German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
  • Division of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pneumologische Schwerpunktpraxis Lübeck, Lübeck, Germany.
  • Global Tuberculosis Program, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montréal, Canada.

Förderung

  • NIAID NIH HHS
  • Forschungszentrum Borstel - Leibniz Lungenzentrum

Zitieren

APA

Brehm, T. T., Köhler, N., Grobbel, H. P., Welling, J., Mandalakas, A. M., Fava, V., Schurr, E., & Lange, C. (2025). High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered?. Infection. https://doi.org/10.1007/s15010-024-02470-z

Vancouver

Brehm TT, Köhler N, Grobbel HP, Welling J, Mandalakas AM, Fava V, et al. High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered?. Infection. 2025. doi:10.1007/s15010-024-02470-z

BibTeX
@article{Brehm2025,
  author = {Brehm, Thomas Theo and Köhler, Niklas and Grobbel, Hans-Peter and Welling, Jürgen and Mandalakas, Anna Maria and Fava, Vinicius and Schurr, Erwin and Lange, Christoph},
  title = {High risk of drug-resistant tuberculosis in IGRA-negative contacts: should preventive treatment be considered?},
  journal = {Infection},
  year = {2025},
  doi = {10.1007/s15010-024-02470-z}
}
Kostenlos starten →